HEADER IMMUNE SYSTEM 09-JUN-24 9C6X TITLE CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF HLA-B*39:01 TITLE 2 Y84C VARIANT, BETA-2MICROGLOBULIN, AND NRVMLPKAA PEPTIDE FROM NLRP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NACHT, LRR AND PYD DOMAINS-CONTAINING PROTEIN 2,BETA-2- COMPND 3 MICROGLOBULIN,MHC CLASS I ANTIGEN; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: NUCLEOTIDE-BINDING SITE PROTEIN 1,PYRIN DOMAIN AND NACHT COMPND 6 DOMAIN-CONTAINING PROTEIN 1,PYRIN-CONTAINING APAF1-LIKE PROTEIN 2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NLRP2, NALP2, NBS1, PAN1, PYPAF2, B2M, CDABP0092, HDCMA22P, SOURCE 6 HLA-B; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HUMAN EMBRYONIC KIDNEY; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PIRES-ACGFP KEYWDS HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-39 ALPHA CHAIN, BETA-2- KEYWDS 2 MICROGLOBULIN, NLRP2, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.SHARMA,N.P.AMDARE,A.CELIKGIL,S.J.GARFORTH,T.P.DILORENZO,S.C.ALMO, AUTHOR 2 A.GHOSH REVDAT 2 02-OCT-24 9C6X 1 JRNL REVDAT 1 04-SEP-24 9C6X 0 JRNL AUTH R.SHARMA,N.P.AMDARE,A.GHOSH,J.SCHLOSS,J.SIDNEY,S.J.GARFORTH, JRNL AUTH 2 Y.LOPEZ,A.CELIKGIL,A.SETTE,S.C.ALMO,T.P.DILORENZO JRNL TITL STRUCTURAL AND BIOCHEMICAL ANALYSIS OF HIGHLY SIMILAR HLA-B JRNL TITL 2 ALLOTYPES DIFFERENTIALLY ASSOCIATED WITH TYPE 1 DIABETES. JRNL REF J.BIOL.CHEM. V. 300 07702 2024 JRNL REFN ESSN 1083-351X JRNL PMID 39173948 JRNL DOI 10.1016/J.JBC.2024.107702 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.21RC1_5156) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 53241 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 2729 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.8300 - 4.5300 1.00 2822 156 0.1697 0.1747 REMARK 3 2 4.5300 - 3.6000 1.00 2718 144 0.1611 0.1957 REMARK 3 3 3.6000 - 3.1400 1.00 2645 164 0.1920 0.2364 REMARK 3 4 3.1400 - 2.8600 1.00 2712 118 0.2089 0.2273 REMARK 3 5 2.8600 - 2.6500 1.00 2695 127 0.2191 0.2445 REMARK 3 6 2.6500 - 2.5000 1.00 2648 164 0.2156 0.2569 REMARK 3 7 2.5000 - 2.3700 1.00 2622 150 0.2062 0.2617 REMARK 3 8 2.3700 - 2.2700 1.00 2638 133 0.2178 0.2242 REMARK 3 9 2.2700 - 2.1800 1.00 2649 150 0.2221 0.2534 REMARK 3 10 2.1800 - 2.1100 1.00 2633 146 0.2218 0.3040 REMARK 3 11 2.1100 - 2.0400 1.00 2662 146 0.2287 0.2315 REMARK 3 12 2.0400 - 1.9800 1.00 2620 153 0.2302 0.2833 REMARK 3 13 1.9800 - 1.9300 1.00 2652 134 0.2366 0.2787 REMARK 3 14 1.9300 - 1.8800 1.00 2623 142 0.2307 0.2650 REMARK 3 15 1.8800 - 1.8400 1.00 2637 137 0.2278 0.2465 REMARK 3 16 1.8400 - 1.8000 1.00 2652 142 0.2365 0.2765 REMARK 3 17 1.8000 - 1.7600 1.00 2609 129 0.2330 0.2492 REMARK 3 18 1.7600 - 1.7300 1.00 2629 147 0.2400 0.2448 REMARK 3 19 1.7300 - 1.7000 1.00 2646 147 0.2613 0.3209 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 NULL REMARK 3 ANGLE : 0.815 NULL REMARK 3 CHIRALITY : 0.053 462 REMARK 3 PLANARITY : 0.006 595 REMARK 3 DIHEDRAL : 16.369 1245 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9C6X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-24. REMARK 100 THE DEPOSITION ID IS D_1000284912. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9201 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53287 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 24.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 0.55000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350 AND 0.1 M TRIS, PH 8.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.21050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.21050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.96950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.06150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.96950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.06150 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 75.21050 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.96950 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.06150 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 75.21050 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.96950 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.06150 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2510 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 990 REMARK 465 GLY A 991 REMARK 465 GLY A 992 REMARK 465 GLY A 993 REMARK 465 GLY A 994 REMARK 465 SER A 995 REMARK 465 GLY A 996 REMARK 465 GLY A 997 REMARK 465 GLY A 998 REMARK 465 MET A 1980 REMARK 465 GLY A 1981 REMARK 465 GLY A 1982 REMARK 465 GLY A 1983 REMARK 465 GLY A 1984 REMARK 465 SER A 1985 REMARK 465 GLY A 1986 REMARK 465 GLY A 1987 REMARK 465 GLY A 1988 REMARK 465 GLY A 1989 REMARK 465 SER A 1990 REMARK 465 GLY A 1991 REMARK 465 GLY A 1992 REMARK 465 GLY A 1993 REMARK 465 GLY A 1994 REMARK 465 SER A 1995 REMARK 465 GLY A 1996 REMARK 465 GLY A 1997 REMARK 465 GLY A 1998 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A1049 -7.94 82.15 REMARK 500 TRP A1061 -0.23 77.99 REMARK 500 THR A1074 -169.25 -126.86 REMARK 500 ASP A2029 -121.64 46.43 REMARK 500 SER A2131 -6.55 -142.09 REMARK 500 SER A2195 -166.81 77.79 REMARK 500 ARG A2239 -26.42 92.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4O2E RELATED DB: PDB REMARK 900 A PEPTIDE COMPLEXED WITH HLA-B*3901 REMARK 900 RELATED ID: 9C6V RELATED DB: PDB REMARK 900 RELATED ID: 9C6W RELATED DB: PDB DBREF 9C6X A 323 331 UNP Q9NX02 NALP2_HUMAN 323 331 DBREF 9C6X A 1002 1980 UNP P61769 B2MG_HUMAN 21 119 DBREF 9C6X A 2001 2274 UNP R5AK10 R5AK10_HUMAN 25 298 SEQADV 9C6X GLY A 332 UNP Q9NX02 LINKER SEQADV 9C6X CYS A 333 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 334 UNP Q9NX02 LINKER SEQADV 9C6X ALA A 335 UNP Q9NX02 LINKER SEQADV 9C6X SER A 990 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 991 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 992 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 993 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 994 UNP Q9NX02 LINKER SEQADV 9C6X SER A 995 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 996 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 997 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 998 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 999 UNP Q9NX02 LINKER SEQADV 9C6X SER A 1000 UNP Q9NX02 LINKER SEQADV 9C6X MET A 1001 UNP Q9NX02 LINKER SEQADV 9C6X GLY A 1981 UNP P61769 LINKER SEQADV 9C6X GLY A 1982 UNP P61769 LINKER SEQADV 9C6X GLY A 1983 UNP P61769 LINKER SEQADV 9C6X GLY A 1984 UNP P61769 LINKER SEQADV 9C6X SER A 1985 UNP P61769 LINKER SEQADV 9C6X GLY A 1986 UNP P61769 LINKER SEQADV 9C6X GLY A 1987 UNP P61769 LINKER SEQADV 9C6X GLY A 1988 UNP P61769 LINKER SEQADV 9C6X GLY A 1989 UNP P61769 LINKER SEQADV 9C6X SER A 1990 UNP P61769 LINKER SEQADV 9C6X GLY A 1991 UNP P61769 LINKER SEQADV 9C6X GLY A 1992 UNP P61769 LINKER SEQADV 9C6X GLY A 1993 UNP P61769 LINKER SEQADV 9C6X GLY A 1994 UNP P61769 LINKER SEQADV 9C6X SER A 1995 UNP P61769 LINKER SEQADV 9C6X GLY A 1996 UNP P61769 LINKER SEQADV 9C6X GLY A 1997 UNP P61769 LINKER SEQADV 9C6X GLY A 1998 UNP P61769 LINKER SEQADV 9C6X GLY A 1999 UNP P61769 LINKER SEQADV 9C6X SER A 2000 UNP P61769 LINKER SEQADV 9C6X CYS A 2084 UNP R5AK10 TYR 108 VARIANT SEQRES 1 A 418 ASN ARG VAL MET LEU PRO LYS ALA ALA GLY CYS GLY ALA SEQRES 2 A 418 SER GLY GLY GLY GLY SER GLY GLY GLY GLY SER MET ILE SEQRES 3 A 418 GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS PRO SEQRES 4 A 418 ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR VAL SEQRES 5 A 418 SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU LEU SEQRES 6 A 418 LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER ASP SEQRES 7 A 418 LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU TYR SEQRES 8 A 418 TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR ALA SEQRES 9 A 418 CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS ILE SEQRES 10 A 418 VAL LYS TRP ASP ARG ASP MET GLY GLY GLY GLY SER GLY SEQRES 11 A 418 GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY GLY SEQRES 12 A 418 SER GLY SER HIS SER MET ARG TYR PHE TYR THR SER VAL SEQRES 13 A 418 SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE SER VAL SEQRES 14 A 418 GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER SEQRES 15 A 418 ASP ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP SEQRES 16 A 418 ILE GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG ASN THR SEQRES 17 A 418 GLN ILE CYS LYS THR ASN THR GLN THR ASP ARG GLU SER SEQRES 18 A 418 LEU ARG ASN LEU ARG GLY CYS TYR ASN GLN SER GLU ALA SEQRES 19 A 418 GLY SER HIS THR LEU GLN ARG MET TYR GLY CYS ASP VAL SEQRES 20 A 418 GLY PRO ASP GLY ARG LEU LEU ARG GLY HIS ASN GLN PHE SEQRES 21 A 418 ALA TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP SEQRES 22 A 418 LEU SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE SEQRES 23 A 418 THR GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN SEQRES 24 A 418 LEU ARG THR TYR LEU GLU GLY THR CYS VAL GLU TRP LEU SEQRES 25 A 418 ARG ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG SEQRES 26 A 418 ALA ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SEQRES 27 A 418 SER ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY SEQRES 28 A 418 PHE TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP SEQRES 29 A 418 GLY GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR SEQRES 30 A 418 ARG PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA SEQRES 31 A 418 VAL VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS SEQRES 32 A 418 HIS VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU SEQRES 33 A 418 ARG TRP HET P4G A2301 11 HET EDO A2302 4 HETNAM P4G 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 P4G C8 H18 O3 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *250(H2 O) HELIX 1 AA1 ALA A 2049 GLU A 2053 5 5 HELIX 2 AA2 GLY A 2056 TYR A 2085 1 30 HELIX 3 AA3 ASP A 2137 ALA A 2150 1 14 HELIX 4 AA4 ARG A 2151 GLY A 2162 1 12 HELIX 5 AA5 GLY A 2162 GLY A 2175 1 14 HELIX 6 AA6 GLY A 2175 GLN A 2180 1 6 HELIX 7 AA7 GLU A 2253 GLN A 2255 5 3 SHEET 1 AA1 4 LYS A1007 SER A1012 0 SHEET 2 AA1 4 ASN A1022 PHE A1031 -1 O ASN A1025 N TYR A1011 SHEET 3 AA1 4 PHE A1063 PHE A1071 -1 O TYR A1067 N CYS A1026 SHEET 4 AA1 4 GLU A1051 HIS A1052 -1 N GLU A1051 O TYR A1068 SHEET 1 AA2 4 LYS A1007 SER A1012 0 SHEET 2 AA2 4 ASN A1022 PHE A1031 -1 O ASN A1025 N TYR A1011 SHEET 3 AA2 4 PHE A1063 PHE A1071 -1 O TYR A1067 N CYS A1026 SHEET 4 AA2 4 SER A1056 PHE A1057 -1 N SER A1056 O TYR A1064 SHEET 1 AA3 4 GLU A1045 ARG A1046 0 SHEET 2 AA3 4 GLU A1037 LYS A1042 -1 N LYS A1042 O GLU A1045 SHEET 3 AA3 4 TYR A1079 ASN A1084 -1 O ARG A1082 N ASP A1039 SHEET 4 AA3 4 LYS A1092 LYS A1095 -1 O VAL A1094 N CYS A1081 SHEET 1 AA4 8 GLU A2046 PRO A2047 0 SHEET 2 AA4 8 THR A2031 ASP A2037 -1 N ARG A2035 O GLU A2046 SHEET 3 AA4 8 ARG A2021 VAL A2028 -1 N GLY A2026 O PHE A2033 SHEET 4 AA4 8 HIS A2003 VAL A2012 -1 N THR A2010 O ILE A2023 SHEET 5 AA4 8 THR A2094 VAL A2103 -1 O VAL A2103 N HIS A2003 SHEET 6 AA4 8 LEU A2109 TYR A2118 -1 O LEU A2110 N ASP A2102 SHEET 7 AA4 8 LYS A2121 LEU A2126 -1 O LEU A2126 N ASN A2114 SHEET 8 AA4 8 TRP A2133 ALA A2135 -1 O THR A2134 N ALA A2125 SHEET 1 AA5 4 LYS A2186 ILE A2194 0 SHEET 2 AA5 4 GLU A2198 PHE A2208 -1 O TRP A2204 N HIS A2188 SHEET 3 AA5 4 PHE A2241 PRO A2250 -1 O ALA A2245 N CYS A2203 SHEET 4 AA5 4 GLU A2229 LEU A2230 -1 N GLU A2229 O ALA A2246 SHEET 1 AA6 4 LYS A2186 ILE A2194 0 SHEET 2 AA6 4 GLU A2198 PHE A2208 -1 O TRP A2204 N HIS A2188 SHEET 3 AA6 4 PHE A2241 PRO A2250 -1 O ALA A2245 N CYS A2203 SHEET 4 AA6 4 ARG A2234 PRO A2235 -1 N ARG A2234 O GLN A2242 SHEET 1 AA7 4 GLU A2222 ASP A2223 0 SHEET 2 AA7 4 THR A2214 ARG A2219 -1 N ARG A2219 O GLU A2222 SHEET 3 AA7 4 TYR A2257 GLN A2262 -1 O HIS A2260 N THR A2216 SHEET 4 AA7 4 LEU A2270 LEU A2272 -1 O LEU A2272 N CYS A2259 SSBOND 1 CYS A 333 CYS A 2084 1555 1555 2.04 SSBOND 2 CYS A 1026 CYS A 1081 1555 1555 2.02 SSBOND 3 CYS A 2101 CYS A 2164 1555 1555 2.09 SSBOND 4 CYS A 2203 CYS A 2259 1555 1555 2.02 CISPEP 1 HIS A 1032 PRO A 1033 0 3.07 CISPEP 2 TYR A 2209 PRO A 2210 0 2.31 CRYST1 75.939 84.123 150.421 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013168 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011887 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006648 0.00000